Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shannon M Conley

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 17, 2013
Persistence of non-viral vector mediated RPE65 expression: case for viability as a gene transfer therapy for RPE-based diseasesAdarsha Koirala, Shannon M Conley, Rasha Makkia, et al.
Investigative Ophthalmology & Visual Science|June 10, 2020
Elimination of a Retinal Riboflavin Binding Protein Exacerbates Degeneration in a Model of Cone-Rod DystrophyAyse M Genc, Mustafa S Makia, Tirthankar Sinha, et al.
Human Molecular Genetics|January 28, 2014
Insights into the mechanisms of macular degeneration associated with the R172W mutation in RDSShannon M Conley, Michael W Stuck, Justin L Burnett, et al.
International Journal of Nanomedicine|March 23, 2018
DNA nanoparticles are safe and nontoxic in non-human primate eyesRyan A Kelley, Shannon M Conley, Rasha Makkia, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 28, 2022
Prph2 disease mutations lead to structural and functional defects in the RPELars Tebbe, Haarthi Sakthivel, Mustafa S Makia, et al.
Human Molecular Genetics|July 28, 2020
ROM1 contributes to phenotypic heterogeneity in PRPH2-associated retinal diseaseDaniel Strayve, Mustafa S Makia, Mashal Kakakhel, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 26, 2015
Genomic DNA nanoparticles rescue rhodopsin-associated retinitis pigmentosa phenotypeZongchao Han, Marcellus J Banworth, Rasha Makkia, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 10, 2020
Novel molecular mechanisms for Prph2-associated pattern dystrophyDibyendu Chakraborty, Daniel G Strayve, Mustafa S Makia, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2020
Syntaxin 3 is essential for photoreceptor outer segment protein trafficking and survivalMashal Kakakhel, Lars Tebbe, Mustafa S Makia, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 31, 2025
Endothelial-to-mesenchymal transition in the central nervous system: A potential therapeutic target to combat age-related vascular fragilityMichaela L Vance, Dorina Nagy, Evelyn Brunner, et al.
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 17, 2013
Persistence of non-viral vector mediated RPE65 expression: case for viability as a gene transfer therapy for RPE-based diseasesAdarsha Koirala, Shannon M Conley, Rasha Makkia, et al.
Investigative Ophthalmology & Visual Science|June 10, 2020
Elimination of a Retinal Riboflavin Binding Protein Exacerbates Degeneration in a Model of Cone-Rod DystrophyAyse M Genc, Mustafa S Makia, Tirthankar Sinha, et al.
Human Molecular Genetics|January 28, 2014
Insights into the mechanisms of macular degeneration associated with the R172W mutation in RDSShannon M Conley, Michael W Stuck, Justin L Burnett, et al.
International Journal of Nanomedicine|March 23, 2018
DNA nanoparticles are safe and nontoxic in non-human primate eyesRyan A Kelley, Shannon M Conley, Rasha Makkia, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 28, 2022
Prph2 disease mutations lead to structural and functional defects in the RPELars Tebbe, Haarthi Sakthivel, Mustafa S Makia, et al.
Human Molecular Genetics|July 28, 2020
ROM1 contributes to phenotypic heterogeneity in PRPH2-associated retinal diseaseDaniel Strayve, Mustafa S Makia, Mashal Kakakhel, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 26, 2015
Genomic DNA nanoparticles rescue rhodopsin-associated retinitis pigmentosa phenotypeZongchao Han, Marcellus J Banworth, Rasha Makkia, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 10, 2020
Novel molecular mechanisms for Prph2-associated pattern dystrophyDibyendu Chakraborty, Daniel G Strayve, Mustafa S Makia, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2020
Syntaxin 3 is essential for photoreceptor outer segment protein trafficking and survivalMashal Kakakhel, Lars Tebbe, Mustafa S Makia, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 31, 2025
Endothelial-to-mesenchymal transition in the central nervous system: A potential therapeutic target to combat age-related vascular fragilityMichaela L Vance, Dorina Nagy, Evelyn Brunner, et al.
Pageof 9